172 related articles for article (PubMed ID: 12841851)
1. CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.
Elias AN; Nanda VS; Barr RJ
BMC Dermatol; 2003 Jul; 3():3. PubMed ID: 12841851
[TBL] [Abstract][Full Text] [Related]
2. Effect of PTU on IL-12 and IL-10 in psoriasis.
Elias AN; Nanda VS; Barr RJ
J Drugs Dermatol; 2003 Dec; 2(6):645-8. PubMed ID: 14711144
[TBL] [Abstract][Full Text] [Related]
3. p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene.
Elias AN; Barr RJ; Nanda VS
Int J Dermatol; 2004 Dec; 43(12):889-92. PubMed ID: 15569009
[TBL] [Abstract][Full Text] [Related]
4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
5. Anti-thyroid thioureylenes in the treatment of psoriasis.
Elias AN
Med Hypotheses; 2004; 62(3):431-7. PubMed ID: 14975517
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis.
Gnanaraj P; Dayalan H; Elango T; Malligarjunan H; Raghavan V; Rao R
Int J Dermatol; 2015 Mar; 54(3):302-6. PubMed ID: 25267471
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study.
Gnanaraj P; Malligarjunan H; Dayalan H; Karthikeyan S; Narasimhan M
Indian J Dermatol Venereol Leprol; 2011; 77(6):673-6. PubMed ID: 22016273
[TBL] [Abstract][Full Text] [Related]
8. Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene.
Elias AN; Nanda VS; Pandian R
BMC Dermatol; 2004 Apr; 4():4. PubMed ID: 15119959
[TBL] [Abstract][Full Text] [Related]
9. Oral propylthiouracil for the treatment of resistant plaque psoriasis.
Chowdhury MM; Marks R
J Dermatolog Treat; 2001 Jun; 12(2):81-5. PubMed ID: 12243663
[TBL] [Abstract][Full Text] [Related]
10. Enhanced apoptosis in psoriatic plaques after treatment with propylthiouracil.
Elias AN; Barr RJ
Eur J Dermatol; 2007; 17(4):353-4. PubMed ID: 17540660
[No Abstract] [Full Text] [Related]
11. Effect of orally administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions.
Elias AN; Barr RJ; Rohan MK; Dangaran K
Int J Dermatol; 1995 Apr; 34(4):280-3. PubMed ID: 7790147
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients.
Malligarjunan H; Gnanaraj P; Subramanian S; Elango T; Dayalan H
Clin Biochem; 2011 Oct; 44(14-15):1209-13. PubMed ID: 21820424
[TBL] [Abstract][Full Text] [Related]
13. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
14. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis.
Elias AN; Goodman MM; Rohan MK
Int J Dermatol; 1993 Jul; 32(7):537-40. PubMed ID: 8340196
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
16. Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests.
Aydemir S; Bayraktaroglu T; Demircan N; Sert M; Açikgoz S; Tekin IO; Ustundag Y
Int J Clin Pract; 2005 Nov; 59(11):1304-8. PubMed ID: 16236085
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant potential of propylthiouracil in patients with psoriasis.
Utaş S; Köse K; Yazici C; Akdaş A; Keleştimur F
Clin Biochem; 2002 May; 35(3):241-6. PubMed ID: 12074833
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
19. Serum ICAM-1 concentrations in patients with psoriasis treated with antithyroid thioureylenes.
Elias AN; Goodman MM; Rohan MK
Clin Exp Dermatol; 1993 Nov; 18(6):526-9. PubMed ID: 7902785
[TBL] [Abstract][Full Text] [Related]
20. Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin.
Heier I; Søyland E; Krogstad AL; Rodríguez-Gallego C; Nenseter MS; Jahnsen FL
Br J Dermatol; 2011 Oct; 165(4):792-801. PubMed ID: 21623747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
